Abstract
The hydrate, methanolate, ethanolate, and isopropanolate solvatomorphs of erythromycin A have been prepared and characterized as to their crystallographic and solvent content characteristics. Even though erythromycin A does not exhibit fluorescence when in a dissolved state, in the solid state the solvated materials were found to be mildly fluorescent. Differences in fluorescence intensity were noted among the solvatomorphs, which could be roughly correlated with the degree of crystallinity of the materials. Desolvation of the dihydrate phase (known to yield an isomorphic desolvate) led to only minor changes in the excitation and emission spectra, but desolvation of the alchoholate solvatomorphs (known to yield largely amorphous products) caused large decreases in the intensities of the excitation and emission spectra. Since the fluorescence properties of organic solids are critically dependent on the details of the crystal structure and the delocalization of excitation energy, the loss of crystal structure appears to suppress the degree of energy transfer and this in turn affects the fluorescence intensities.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Allen PV, Rahn PD, Sarapu AC, Vanderwielen AJ (1978). “Physical Characterization of Erythromycin: Anhydrate, Monohydrate, and Dihydrate Crystalline Solids.” J. Pharm. Sci., 67, 1087–1093.
Bauer J, Quick J, Oheim R. (1985). “Alternate Interpretation of the Role of Water in the Erythromycin Structure.” J. Pharm. Sci., 74, 899–900.
Bernstein J (2002). “Analytical Techniques for Studying and Characterizing Polymorphs.” in Polymorphism in Molecular Crystals, Clarendon Press, London, pp. 94–150.
Brittain HG (1997). “Spectral Methods for the Characterization of Polymorphs and Solvates.” J. Pharm. Sci., 86, 405–412.
Brittain HG (1999). “Methods for the Characterization of Polymorphs and Solvates.” in Polymorphism in Pharmaceutical Solids, Brittain HG ed.;: Marcel Dekker, New York, pp. 227–278.
Brittain HG, Elder BJ, Isbester PK, Salerno AH (2005a). “Solid-State Fluorescence Studies of Some Polymorphs of Diflunisal.” Pharm. Res., 22, 999–1006.
Brittain HG (2005b). “Solid-State Fluorescence of the Trihydrate Phases of Ampicillin and Amoxicillin”, AAPS PharmSciTech, 6(3), article 55.
Brittain HG (2006). “Luminescence Spectroscopy.” in Spectroscopy of Pharmaceutical Solids, Brittain HG ed., Taylor & Francis, New York, pp. 151–204.
Craig DP, Walmsley SH (1968). Excitons in Molecular Crystals. W.A. Benjamin, New York.
Davydov AS (1962). Theory of Molecular Excitons. McGraw-Hill, New York.
Fukumori Y, Fukuda T, Yamamoto Y, Shigitani Y, Hanyu Y, Takeuchi Y, Sato N (1983). “Physical Characterization of Erythromycin Dihydrate, Anhydrate and Amorphous Solid and their Dissolution Properties.” Chem. Pharm. Bull., 31, 4029–4039.
Koch WL (1979). “Erythromycin”, in Analytical Profiles of Drug Substances, Florey K, ed., Academic Press, New York, pp. 159–177.
Laine E, Kahela P, Rajala R, Heikkila T, Saarnivaara K, Piippo I (1987). “Crystal Forms and Bioavailability of Erythromycin.” Int. J. Pharm., 38, 33–38.
Merck Index (2001). Merck & Co., Inc., Whitehouse Station, NJ, pp. 654–655.
Miroshnyk I, Khriachtchev L, Mirza S, Rantanen J, Heinamaki J, Yliruusi J (2006). “Insight into Thermally Induced Phase Transformations of Erythromycin A Dihydrate.” Cryst. Growth Design, 6, 369–374.
Mirza S, Miroshnyk I, Heinamaki J, Christiansen L, Karjalainen M, Yliruusi J (2003). “Influence of Solvents on the Variety of Crystalline Forms of Erythromycin”. AAPS PharmSci, 5(2), article 12.
Murthy KS, Turner NA, Nesbitt RU, Fawzi MB (1986). “Characterization of Commercial Lots of Erythromycin Base.” Drug Dev. Indust. Pharm., 12, 665–690.
Sarisuta N, Kumpugdee M, Muller BW, Puttipipatkhachorn S (1999). “Physico-Chemical Characterization of Interactions Between Erythromycin and Various Film Polymers.” Int. J. Pharm., 186, 109–118.
Stephenson GA, Stowell JG, Pascal HT, Pfeiffer RR, Byrn SR (1997). “Solid-State Investigations of Erythromycin A Dihydrate: Structure, NMR Spectroscopy, and Hygroscopicity.” J. Pharm. Sci., 86, 1239–1244.
Stephenson GA, Groleau EG, Kleemann RL, Xu W, Rigsbee DR (1998). “Formation of Isomorphic Desolvates: Creating a Molecular Vacuum.” J. Pharm. Sci., 87, 536–542.
Threlfall TL (1995). “Analysis of Organic Polymorphs – A Review.” Analyst, 120, 2435–2460.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Copyright information
© 2009 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Brittain, H.G. (2009). Photoluminescence of Pharmaceutical Materials in the Solid State. 4. Fluorescence Studies of Various Solvated and Desolvated Solvatomorphs of Erythromycin A. In: Reviews in Fluorescence 2007. Reviews in Fluorescence, vol 2007. Springer, New York, NY. https://doi.org/10.1007/978-0-387-88722-7_16
Download citation
DOI: https://doi.org/10.1007/978-0-387-88722-7_16
Publisher Name: Springer, New York, NY
Print ISBN: 978-0-387-88721-0
Online ISBN: 978-0-387-88722-7
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)